Adrian van den Hoven, Director General, Medicines for Europe

#114 What Are the Generic and Biosimilar Industries Worried About? Current Competition Law Issues Impacting the Sector.

Generics and biosimilars are an important part of the pharmaceutical landscape in Europe. What are […]

What’s All The Fuss About? Brexit and UK Competition Law

#100 What’s All The Fuss About? Brexit and UK Competition Law

The UK has finally left the EU and the ambit of EU law. What does […]

Can They Really Say That? Product Denigration Under French Antitrust Law

#96 Can They Really Say That? Product Denigration Under French Antitrust Law

At its most basic, marketing often consists of simply explaining a product’s qualities relative to […]